Tuberculosis clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum
open to eligible females
The purpose of this study is to evaluate the pharmacokinetic (PK) properties of antiretroviral (ARV) and anti-tuberculosis (TB) drugs administered during pregnancy and postpartum.
at UCLA UCSD
Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals
Sorry, currently not accepting new patients, but might later
This study will evaluate the potential drug-drug interactions between dolutegravir (DTG) and steady state rifapentine (RPT) when RPT is given with isoniazid (INH) daily for 4 weeks (1HP) as part of treatment for latent TB infection (LTBI) in HIV-1 and LTBI co-infected individuals.
at UCSF
Last updated: